CNTA vs UNP · $6.15B cap vs P/E 21, rev $6.86B
Centessa Pharmaceuticals PLC ADR (CNTA) versus Union Pacific Corporation (UNP) — a side-by-side from cached financials, not a winner call.
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
Union Pacific Corporation (UNP) is a railroads company listed on NYSE.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
Latest reported UNP revenue for 2026-06-30 was $6.86B. Net income was $1.99B. Revenue was up 10.4% from 2026-03-31 to 2026-06-30. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
CNTA currently screens at market cap $6.15B. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
Not investment advice. Open the CNTA and UNP stock pages for the full models.
Not investment advice.